1. Research Goal
We are aiming to develop theranostic nanobio-platform systems using biomolecules, biomaterials, nanomateirlas and/or their hybrids:
- Diagnostic nanobiosensors (using aptamers, peptides, proteins, and nanomaterials)
- Therapeutic methods (using EV/protein delivery or photodynamic therapy)
By implementing these platform technologies, we focus on diagnostics and therapy by controlling biological processes and functions, but also address fundamental problems in the interface of life science field:
- Investigating disease diagnostics and therapy
: Bioluminescence-induced cancer diagnosis and photodynamic therapy
: Aptamer/DNAzyme-facilitated cancer targeting and imaging of ncRNAs, small molecules, and cells
: Protein-based sensing and imaging of ROS in living organisms
: Protein delivery via smart nano-cargo and/or protein modification
- Exploring PTMs and protein Interactions
: In vitro and cell imaging-based analysis of protein kinase, phosphatase, and/or protease activity
: Analyzing protein-DNA or protein-ligand interactions
- Discovering new biomarkers in diseases
: Discovering surafce biomarkers through proximity labeling technology in EVs and cells
By implementing these platform technologies, we are targeting diseases as follows:
- Cancers (breast, lung, and brain)
- Inflammatory bowel disease
- Skin inflammation
Fig. 1. Current Researches in Lab of Nanobiology, HYU (2011~present)
2. Research Area
The above objectives will be contributing to one or more of the following multidisciplinary areas:
2-1. Biomedicine/Nanomedicine
In vitro diagnosis and in vivo imaging of cancer/disease biomarkers with sensitively designed probes
Study on physiological function of enzyme activity related to tumor metastasis and drug resistance
Photodynamic cancer therapy with endogenous and exogenous light illumination
Protein delivery into living cells for targeted therapy
2-2. Biological/Environmental Sciences
Library screening of aptamers/peptides to study cellular functions and protein interactions
Diagnosis and imaging of virus, pathogenic bacteria, small molecules, biomarkers, or cells
Convergence of life science with chemistry, physics, and nanotechnology.
2-3. Biotechnology/Nanobiotechnology
Engineering biomolecules (Protein/DNA) for the development of biosensors
Designing nanomaterials/biomaterials for the development of biosensors
Keyword 1 (Field): Biosensor, Nanosensor, Bioimaging, Biomaterials, Diagnostics, Delivery, Theranostics
Keyword 2 (Material): Bioluminescence, Aptamer, Extracellular Vesicle, ROS
Keyword 2 (Method): Photodynamic Therapy, Proximity labeling, BRET/FRET, Protein Delivery
3. Representative Research Achievements
3-1. Aptamer-based biosensors and nanosensors through GNP-SELEX
(GNP-SELEX를 이용한 압타머 기반의 바이오센서 및 나노센서)
1) Overview
The traditional systematic evolution of ligands by exponential enrichment (SELEX) process is time-consuming and imperceptible
2) Scientific Specialty and Levels
Gold nanoaprticle-facilitated assembly via supernatant transfer (GNP-FAST) combined with GNP-SELEX is proposed as a visual and straightforward monitoring platform for the rapid discovery of small molecule-binding single-stranded DNA (ssDNA) aptamers
3) Expected Contributions & Future Direction
A colorimetric SELEX platform will facilitate the rapid discovery of ssDNA aptamers against various targets and identify their wide applications in biosensing and bioassays
4) Related References
Biosens. Bioelectron. 2021, 191, 113468
Chemosensors 2021, 9(3), 54
Chemosphere 2019, 228, 110
Sensors and Actuators B-Chemical 2018, 260, 371
Sensors and Actuators B-Chemical 2018, 256, 89
Sensors 2017, 17(12), 2840
Sensors 2014, 14(10), 18302
3-2. Exosome and/or protein delivery for disease therapy
(질병치료를 위한 엑소좀/단백질 전달 연구)
1) Overview
Despite the therapeutic potential of recombinant proteins, their cell permeabilities and stabilities remain significant challenges. Cyclized recombinant proteins can be used as universal cargos for permeable and stable delivery into cells, liposomes, and EVs.
2) Scientific Specialty and Levels
Cyclization of proteins for delivery into cells, liposomes, and exosomes
In silico simulation for membrane penetration
3) Expected Contributions & Future Direction
This strategy will be universally applicable to intercellular delivery of proteins and EVs for therapy
4) Related References
International Journal of Biological Macromolecules 2023, 252; 126520
International Journal of Molecular Sciences 2022, 23(3), 1605
3-3. Proximity labeling & imaging in cellular and extracellar vesicle membranes
(세포막과 EV 막의 근접 표지 및 근접 이미징)
1) Overview
To address the challenge of faint fluorescence (FL) in cell surface-targeted diagnostics, we propose an APEX2-driven proximity imaging technique and a ligand-driven enzyme-accelerated signal enhancement (L-EASE) technique to clearly visualize cancer cells or EVs.
2) Scientific Specialty and Levels
Cyclization of proteins for labeling and imaging in cells and EVs
Enzyme-mediated signal amplification
3) Expected Contributions & Future Direction
These methods will be useful as a universal visualization method with exceptional sensitivity and usability for detecting cancer cells and EVs.
4) Related References
International Journal of Biological Macromolecules 2023, 252; 126520
International Journal of Molecular Sciences 2022, 23(3), 1605
3-4. Bioluminescence-based photodynamic therapy
(생물발광 기반의 광역학 치료)
3-5. FRET(or BRET)-based reporters regarding cell-secreted protease activity
(세포 외 분비 단백질 분해 효소 관련 FRET or BRET 리포터 개발)
1) Overview
A subset of cell-secreted proteases are implicated in a wide range of biological processes in normal and pathological events. For example, activity-based assays of matrix metalloproteinases (MMPs) is a key issue to understand their contributions to tumor progression.
Fluorescence or bioluminescence resonance energy transfer (FRET or BRET) systems between biomolecules and/or nanoparticles bring new insight to detect biomolecular change with higher sensitivity and flexibility.
2) Scientific Specialty and Levels
Although expression profiles of cell-secreted proteases have been reported to be useful in explicating various disease processes, a practical issue in quantifying levels of protease activities in clinical samples remains formidable because only difference in total expression where the correlation might not necessarily be related to disease level. Therefore, emphasis should be placed on the importance of active proteases rather than their expression levels in tumor.
Our designed probes include the sensing part (peptide substrate) and detection part (fluorescence, bioluminescence and/or their energy transferred couplers). Nanoparticles (gold, quantum dot, or polymer-based nanoparticles) have been combined with this system to enhance the sensitivity and other optical properties. This nanohybrid probe can serve as a biosensor and/or an imaging probe for targeting active proteases.
3) Expected Contributions & Future Direction
Protease-related cancer metastasis study based on in vivo diagnostic/imaging of protease activity
Protease activity profiling to address biological function of proteases in vitro and in vivo
4) Related References
ACS Sensors 2020, 5(3), 655
Sensors and Actuators B-Chemical 2019, 281, 527
Sensors 2018, 18(3), 875
Theranostics 2012, 2(2), 127
Chem. Commun. 2010, 46, 76
Biosens. Bioelectron. 2009, 24(5), 1189
Anal. Chem. 2008, 80(13), 5094
Anal. Chem. 2008, 80(12), 4634
3-6. Biosensors for determining biomolecular activities or interactions
(생체분자의 활성 및 상호작용 분석을 위한 바이오센서)
1) Overview
Gold nanoparticle-based colorimetric biosensors for assaying enzyme activity
CRISPR-based diagnostics
FRET/BRET-based biosensors
ROS Biosensors using DNA-Protein interactions
2) Scientific Specialty and Levels
Complicate methods are formidable for the development of biosensors.
There is still a challenge in enhancing FRET/BRET efficiency to avoid high background noise signal.
Despite the implications of rapid influx and oxidation of free LMW biothiols in plasma, current methods are neither sufficiently convenient nor rapid enough to detect free LMW biothiols because free LMW biothiols are susceptible to rapid oxidation.
3) Expected Contributions & Future Directions
Colorimetric assays using gold nanoparticles (AuNPs) is valuable for determining the physiological roles of many protein activities in a rapid and simple way.
QD-FRET/BRET method is anticipated to facilitate applications for studying physiological functions of protein kinases in association with drug development.
We report a novel method for the rapid detection of plasma LMW biothiols using a bacterial redox-sensing transcription repressor protein and its operator DNA element.
4) Related References
Sensors and Actuators B-Chemical 2021, 336, 129735
Analytical Chemistry 2019, 91(15), 10064
Sensors and Actuators B-Chemical 2017, 246, 271
ChemBioChem 2016, 17(4), 275
Sensors 2015, 15(8), 17977
Analytical Chemistry 2015, 87(2), 1257
Biosensors & Bioelectronics 2012, 41(1), 833
Biosensors & Bioelectronics 2012, 41(1), 752
3-7. Biochips for determining enzyme activities or biomolecular interactions
(생체분자의 활성 및 상호작용 분석을 위한 바이오칩)
1) Overview
Microfluidic or mass spectrometric biochips for assaying kinase activity and screening inhibitory drugs
Fluorescence biochips for monitoring cancer biomarkers in conjuction with nanostructures
Microfluidic biochips for determining protein-DNA interactions
Colorimetric biochips for screening ROS scavengers
2) Scientific Specialty and Levels
Most studies to assay enzyme activity and their inhibitors have relied on labor-intensive and time-consuming techniques.
Matrix-free time-of-flight secondary ion mass spectrometry (TOF-SIMS)-based biochips
Based on the observation that secondary ion mass signal of peptides is highly enhanced on AuNPs, this system was applied to the assaying of kinase activity and its inhibition with high detection sensitivity (~fmol/mm2) of the mass change of peptide substrates in a kinase reaction.
Microfluidic biochip for the detection of low-molecular-weight thiols
Based on the protein (repressor)-DNA (binding element) interaction
Microfluidic biochip for the detection of isoelectric points of proteins
3) Expected Contributions & Future Directions
Therapeutic applications for drug development by screening various PTM-related enzymes and their inhibitors with high sensitivity in a high-throughput manner
4) Related References
BioChip Journal 2020, 14, 148
Sensors and Actuators B-Chemical 2018, 256, 89
Anal. Chem. 2017, 89(1), 799
Scientific Reports 2015, 5, 12019
Small 2015, 11(28), 3469
Biosens. Bioelectron. 2015, 73(1), 93
Mass Spectrometry Reviews 2015, 34(2), 237
Anal. Chem. 2006, 78, 1913
Angew. Chem. Int. Ed. 2007, 46, 6816
Biosens. Bioelectron. 2008, 23(7), 980
Files & Links
Useful links
학생 사이트
[링크]
[링크]
[링크]
학부모 사이트
[링크]
[링크]
[링크]
학교 양식
[링크]
[링크]
[링크]
3-2. Bioluminescence-based photodynamic therapy
(생물발광 기반의 광역학 치료)